Search:
Tokushima UniversityGraduate School of Biomedical Sciences医学域先端医学教育研究プロジェクト
Tokushima UniversityGraduate School of Biomedical Sciences医学域Medical ScienceInternal MedicineDepartment of Psychiatry
Tokushima UniversityUniversity HospitalClinical DivisionDepartment of Neurosurgery, Psychiatry and AnesthesiologyPsychiatry
Tokushima UniversityUniversity HospitalClinical DivisionDepartment of Neurosurgery, Psychiatry and AnesthesiologyPsychosomatic Medicine
Tokushima UniversityFaculty of MedicineSchool of MedicineCourse of Integrated Brain SciencesPsychiatry
(Files for researchmap) [PDF manual] [Auto-propagate to researchmap]

Research Activity

Field of Study

Subject of Study

Book / Paper

Book:

1. Hidehiro Umehara :
精神障害各論 生理的障害および身体要因に関連した行動症候群 睡眠覚醒障害,産褥に関連した精神障害,
株式会社 中外医学社, Jan. 2021.

Academic Paper (Judged Full Paper):

1. Yukiko Tomioka, Makoto Kinoshita, Hidehiro Umehara, Tomohiko Nakayama, Shinya Watanabe, Masahito Nakataki, Shusuke Numata and Tetsuro Ohmori :
Association between serum folate levels and schizophrenia based on sex.,
Psychiatry and Clinical Neurosciences, Vol.74, No.9, 466-471, 2020.
(Tokushima University Institutional Repository: 115397,   DOI: 10.1111/pcn.13074,   PubMed: 32445495)
2. 武田 知也, Hidehiro Umehara, 梶田 美香 and Tetsuro Ohmori :
Metacognitive training for depression to elderly woman with depression : A case report,
Japanese Journal of Psychiatric Treatment, Vol.35, No.5, 535-540, 2020.
(CiNii: 40022378899)
3. Tomoya Takeda, Masahito Nakataki, Masashi Ohta, S Hamatani, K Matsuura, R Yoshida, Naomi Kameoka, Takeo Tominaga, Hidehiro Umehara, Makoto Kinoshita, Shinya Watanabe, Shusuke Numata, Satsuki Sumitani and Tetsuro Ohmori :
Negative and positive self-thoughts predict subjective quality of life in people with schizophrenia.,
Neuropsychiatric Disease and Treatment, Vol.15, 293-301, 2019.
(Tokushima University Institutional Repository: 113356,   DOI: 10.2147/NDT.S190381,   PubMed: 30718955,   Elsevier: Scopus)
4. Shusuke Numata, Hidehiro Umehara, Tetsuro Ohmori and R. Hashimoto :
Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and Agranulocytosis.,
Frontiers in Pharmacology, Vol.9, 1049, 2018.
(Tokushima University Institutional Repository: 114908,   DOI: 10.3389/fphar.2018.01049,   PubMed: 30319405)
5. Yukiko Tomioka, Shusuke Numata, Makoto Kinoshita, Hidehiro Umehara, Shinya Watanabe, Masahito Nakataki, Y Iwayama, T Toyota, M Ikeda, H Yamamori, S Shimodera, A Tajima, R Hashimoto, N Iwata, T Yoshikawa and Tetsuro Ohmori :
Decreased serum pyridoxal levels in schizophrenia: meta-analysis and Mendelian randomization analysis.,
Journal of Psychiatry & Neuroscience, Vol.43, No.3, 194-200, 2018.
(Tokushima University Institutional Repository: 114064,   DOI: 10.1503/jpn.170053,   PubMed: 29688875)
6. Masatoshi Inoshita, Hidehiro Umehara, Shinya Watanabe, Masahito Nakataki, Makoto Kinoshita, Yukiko Tomioka, Atsushi Tajima, Shusuke Numata and Tetsuro Ohmori :
Elevated peripheral blood glutamate levels in major depressive disorder.,
Neuropsychiatric Disease and Treatment, Vol.14, 945-953, 2018.
(Tokushima University Institutional Repository: 114063,   DOI: 10.2147/NDT.S159855,   PubMed: 29670355,   Elsevier: Scopus)
7. Hidehiro Umehara, Shusuke Numata, Shinya Watanabe, Yutaka Hatakeyama, Makoto Kinoshita, Yukiko Tomioka, Kiyoshi Nakahara, Takeshi Nikawa and Tetsuro Ohmori :
Altered KYN/TRP, Gln/Glu, and Met/methionine sulfoxide ratios in the blood plasma of medication-free patients with major depressive disorder.,
Scientific Reports, Vol.7, No.1, 4855, 2017.
(Tokushima University Institutional Repository: 110182,   DOI: 10.1038/s41598-017-05121-6,   PubMed: 28687801)
8. Makoto Kinoshita, Shusuke Numata, Atsushi Tajima, H Yamamori, Yuka Yasuda, Michiko Fujimoto, Shinya Watanabe, Hidehiro Umehara, Shinji Shimodera, Takanobu Nakazawa, Masataka Kikuchi, Akihiro Nakaya, Hitoshi Hashimoto, Issei Imoto, Ryota Hashimoto and Tetsuro Ohmori :
Effect of Clozapine on DNA Methylation in Peripheral Leukocytes from Patients with Treatment-Resistant Schizophrenia.,
International Journal of Molecular Sciences, Vol.18, No.3, E632, 2017.
(Tokushima University Institutional Repository: 112399,   DOI: 10.3390/ijms18030632,   PubMed: 28335437,   Elsevier: Scopus)
9. Shinya Watanabe, Shusuke Numata, Junichi Iga, Makoto Kinoshita, Hidehiro Umehara, K Ishii and Tetsuro Ohmori :
Gene expression-based biological test for major depressive disorder: an advanced study.,
Neuropsychiatric Disease and Treatment, Vol.13, 535-541, 2017.
(Tokushima University Institutional Repository: 115650,   DOI: 10.2147/NDT.S120038,   PubMed: 28260899,   Elsevier: Scopus)
10. Hiroko Kubo, Masahito Nakataki, Satsuki Sumitani, Junichi Iga, Shusuke Numata, Naomi Kameoka, Shinya Watanabe, Hidehiro Umehara, Makoto Kinoshita, Masatoshi Inoshita, Mai Tamaru, Masashi Ohta, Chiaki Nakayama-Yamauchi, Yasuhiro Funakoshi, Masafumi Harada and Tetsuro Ohmori :
1H-magnetic resonance spectroscopy study of glutamate-related abnormality in bipolar disorder.,
Journal of Affective Disorders, Vol.208, 139-144, 2017.
(Tokushima University Institutional Repository: 109987,   DOI: 10.1016/j.jad.2016.08.046,   PubMed: 27770643,   Elsevier: Scopus)
11. Makoto Kinoshita, Shusuke Numata, Atsushi Tajima, Akira Nishi, Sho Muraki, Atsushi Tsuchiya, Hidehiro Umehara, Shinya Watanabe, Issei Imoto and Tetsuro Ohmori :
Cumulative effect of the plasma total homocysteine-related genetic variants on schizophrenia risk.,
Psychiatry Research, Vol.246, 833-837, 2016.
(DOI: 10.1016/j.psychres.2016.10.017,   PubMed: 27810229,   Elsevier: Scopus)
12. Hidehiro Umehara, Shusuke Numata, Atsushi Tajima, Akira Nishi, Masahito Nakataki, Issei Imoto, Satsuki Sumitani and Tetsuro Ohmori :
Calcium Signaling Pathway Is Associated with the Long-Term Clinical Response to Selective Serotonin Reuptake Inhibitors (SSRI) and SSRI with Antipsychotics in Patients with Obsessive-Compulsive Disorder.,
PLoS ONE, Vol.11, No.6, e0157232., 2016.
(Tokushima University Institutional Repository: 110039,   DOI: 10.1371/journal.pone.0157232,   PubMed: 27281126,   Elsevier: Scopus)
13. JI Iga, Shinya Watanabe, Shusuke Numata, Hidehiro Umehara, Akira Nishi, Makoto Kinoshita, Masatoshi Inoshita, S Shimodera, H Fujita and Tetsuro Ohmori :
Association study of polymorphism in the serotonin transporter gene promoter, methylation profiles, and expression in patients with major depressive disorder.,
Human Psychopharmacology, Vol.31, No.3, 193-199, 2016.
(DOI: 10.1002/hup.2527,   PubMed: 27005686,   Elsevier: Scopus)
14. Hidehiro Umehara, Shusuke Numata, Makoto Kinoshita, Shinya Watanabe, S Nakaaki, Satsuki Sumitani and Tetsuro Ohmori :
No association between BDNF Val66Met polymorphism and treatment response in obsessive-compulsive disorder in the Japanese population.,
Neuropsychiatric Disease and Treatment, Vol.12, 611-615, 2016.
(Tokushima University Institutional Repository: 115651,   DOI: 10.2147/NDT.S102100,   PubMed: 27042072)
15. Masatoshi Inoshita, Shusuke Numata, Atsushi Tajima, Makoto Kinoshita, Hidehiro Umehara, Hidenaga Yamamori, Ryota Hashimoto, Issei Imoto and Tetsuro Ohmori :
Sex differences of leukocytes DNA methylation adjusted for estimated cellular proportions.,
Biology of Sex Differences, Vol.6, 11, 2015.
(DOI: 10.1186/s13293-015-0029-7,   PubMed: 26113971,   Elsevier: Scopus)
16. Hidehiro Umehara, Shusuke Numata, Atsushi Tajima, Makoto Kinoshita, Shutaro Nakaaki, Issei Imoto, Satsuki Sumitani and Tetsuro Ohmori :
No association between the COMT Val158Met polymorphism and the long-term clinical response in obsessive-compulsive disorder in the Japanese population.,
Human Psychopharmacology, Vol.30, No.5, 372-376, 2015.
(DOI: 10.1002/hup.2485,   PubMed: 26010653,   Elsevier: Scopus)
17. Shinya Watanabe, Junichi Iga, Shusuke Numata, Hidehiro Umehara, Akira Nishi, Makoto Kinoshita, Masatoshi Inoshita and Tetsuro Ohmori :
Polymorphism in the promoter of the gene for the serotonin transporter affects the age of onset of major depressive disorder in the Japanese population.,
Journal of Affective Disorders, Vol.183, 156-158, 2015.
(DOI: 10.1016/j.jad.2015.05.009,   PubMed: 26005777,   Elsevier: Scopus)
18. Shusuke Numata, K Ishii, Atsushi Tajima, Junichi Iga, Makoto Kinoshita, Shinya Watanabe, Hidehiro Umehara, M Fuchikami, S Okada, S Boku, A Hishimoto, S Shimodera, Issei Imoto, S Morinobu and Tetsuro Ohmori :
Blood diagnostic biomarkers for major depressive disorder using multiplex DNA methylation profiles: discovery and validation.,
Epigenetics, Vol.10, No.2, 135-141, 2015.
(DOI: 10.1080/15592294.2014.1003743,   PubMed: 25587773,   Elsevier: Scopus)
19. Y Yoshino, M Abe, Shusuke Numata, S Ochi, Y Mori, T Ishimaru, Makoto Kinoshita, Hidehiro Umehara, K Yamazaki, T Mori, Tetsuro Ohmori and S Ueno :
Missense variants of the alanine:glyoxylate aminotransferase 2 gene are not associated with Japanese schizophrenia patients.,
Progress in Neuro-Psychopharmacology & Biological Psychiatry, Vol.53, 137-141, 2014.
(DOI: 10.1016/j.pnpbp.2014.04.002,   PubMed: 24727203)
20. Hidehiro Umehara, Junichi Iga and Tetsuro Ohmori :
Successful Treatment of Anorexia Nervosa in a 10-year-old Boy with Risperidone Long-acting Injection.,
Clinical Psychopharmacology and Neuroscience, Vol.12, No.1, 65-66, 2014.
(DOI: 10.9758/cpn.2014.12.1.65,   PubMed: 24851123)

Academic Letter:

1. Hidehiro Umehara, Satsuki Sumitani and Tetsuro Ohmori :
Restless legs syndrome with chest and back restlessness as the initial symptom,
Psychiatry and Clinical Neurosciences, Vol.64, No.2, 211, 2010.
(DOI: 10.1111/j.1440-1819.2009.02053.x,   PubMed: 20447017)

Review, Commentary:

1. Hidehiro Umehara :
発達障害概略,
めんたるへるす, 67, 2018.

Proceeding of International Conference:

1. Shinya Watanabe, Hidehiro Umehara, Yukiko Tomioka, Makoto Kinoshita, Masahito Nakataki, Shusuke Numata and Tetsuro Ohmori :
Effects of processing conditions on plasma L-glutamate levels in non-psychiatric healthy subjects.,
6th Congress of AsCNP Asian College of Neuropsychopharmacology, Fukuoka, Oct. 2019.
2. Yukiko Tomioka, Hidehiro Umehara, Shinya Watanabe, Masahito Nakataki, Masuda Rumiko, Kazuaki Mawatari, Takeshi Nikawa, Akira Takahashi, Shusuke Numata and Tetsuro Ohmori :
Altered plasma metabolites related to one-carbon metabolism in schizophrenia.,
WFSBP Asia Pacific Regional Congress of Biological Psychiatry, Kobe, Sep. 2018.
3. Hidehiro Umehara, Shinya Watanabe, Makoto Kinoshita, Shusuke Numata and Tetsuro Ohmori :
Pharmacometabolomic changes following antidepressants in patients with major depressive disorder.,
5th Congress of Asian College of Neuropsychopharmacology, Indonesia, Apr. 2017.
4. Shinya Watanabe, Hidehiro Umehara, Makoto Kinoshita, Kazuo Ishii, Shusuke Numata and Tetsuro Ohmori :
Gene expression-based diagnostic marker for bipolar disorder.,
5th Congress of Asian College of Neuropsychopharmacology, Indonesia, Apr. 2017.
5. Hidehiro Umehara, Shusuke Numata, Shinya Watanabe, Satsuki Sumitani and Tetsuro Ohmori :
Altered Serotonin transporter mRNA expression in the peripheral leukocytes of obsessive-compulsive disorder.,
30th CINP World Congress of Neuropsychopharmacology, Seoul, Jul. 2016.
6. Hidehiro Umehara, Shusuke Numata, Atsushi Tajima, A NISHI, Issei Imoto, Satsuki Sumitani and Tetsuro Ohmori :
A genome-wide association study of the long-term clinical response to SSRI or SSRI with antipsychotics in obsessive-compulsive disorder in the Japanese population,
Neuroscience, Chicago, Oct. 2015.
7. Shusuke Numata, Ishii Kazuo, Atsushi Tajima, Junichi Iga, Makoto Kinoshita, Shinya Watanabe, Hidehiro Umehara, Fuchikami Manabu, Okada Satoshi, Shimodera Shinji, Issei Imoto, Morinobu Shigeru and Tetsuro Ohmori :
Blood diagnostic biomarkers for major depressive disorder using DNA methylation profiles.,
Neuroscience, Washington DC, Nov. 2014.
8. Hidehiro Umehara, Shusuke Numata, Atsushi Tajima, Makoto Kinoshita, Nakaaki Shutaro, Issei Imoto, Satsuki Sumitani and Tetsuro Ohmori :
Association between the COMT Val158Met polymorphism and the clinical response to SSRI or SSRI with antipsychotics in obsessive-compulsive disorder.,
Neuroscience, Washington DC, Nov. 2014.

Proceeding of Domestic Conference:

1. Hidehiro Umehara, Tomoya Takeda and Tetsuro Ohmori :
社会認知リハビリテーションプログラムの児童思春期自閉スペクトラム症における社会認知機能への効果とQOLとの関連,
第60回日本児童青年精神医学会, Dec. 2019.
2. Hidehiro Umehara, 戸田 裕之, 斎藤 拓, Masahito Nakataki, Shusuke Numata and Tetsuro Ohmori :
うつ病患者における養育環境のDNAメチル化修飾への影響の検討,
第16回日本うつ病学会総会, Jul. 2019.
3. Makoto Kinoshita, Hidehiro Umehara, Shinya Watanabe, Masahito Nakataki, Atsushi Tajima, Shusuke Numata and Tetsuro Ohmori :
統合失調症における網羅的血漿ホモシステイン濃度関連遺伝子同定研究,
第41回日本生物学的精神医学会, Jun. 2019.
4. 青井 駿, Hidehiro Umehara, Aya Gohji, 東田 義広, Shinya Watanabe, Masahito Nakataki, Shusuke Numata and Tetsuro Ohmori :
感冒症状後にチック症状と強迫症状の出現増悪を認め,PANDASが疑われた1例,
第115回日本精神神経学会学術総会, Jun. 2019.
5. Yukiko Tomioka, Masahito Nakataki, Hidehiro Umehara, Shinya Watanabe, Shusuke Numata and Tetsuro Ohmori :
統合失調症患者における血清葉酸濃度の検討,
第14回日本統合失調症学会, Apr. 2019.
6. Masahito Nakataki, Hiroko Kubo, Satsuki Sumitani, Shusuke Numata, Naomi Kameoka, Shinya Watanabe, Hidehiro Umehara, Masashi Ohta, Masafumi Harada and Tetsuro Ohmori :
双極性障害患者におけるアミノ酸系神経伝達物質の異常,
第15回日本うつ病学会総会, Jul. 2018.
7. Masatoshi Inoshita, Hidehiro Umehara, Shinya Watanabe, Masahito Nakataki, Makoto Kinoshita, Yukiko Tomioka, Atsushi Tajima, Shusuke Numata and Tetsuro Ohmori :
うつ病患者の末梢血グルタミン酸濃度のメタ解析,
第15回日本うつ病学会総会, Jul. 2018.
8. Hidehiro Umehara, Shinya Watanabe, Masahito Nakataki, Shusuke Numata and Tetsuro Ohmori :
うつ病の末梢白血球におけるSGK1遺伝子発現,
第15回日本うつ病学会総会, Jul. 2018.
9. Yukiko Tomioka, Shusuke Numata, Makoto Kinoshita, Hidehiro Umehara, Shinya Watanabe, Masahito Nakataki, 岩山 佳美, 豊田 倫子, 池田 匡志, 山森 英長, 下寺 信次, Atsushi Tajima, 橋本 亮太, 岩田 仲生, 吉川 武男 and Tetsuro Ohmori :
血清ピリドキサール(ビタミンB6)と統合失調症の関連研究,
第13回日本統合失調症学会, Mar. 2018.
10. Tomoya Takeda, Masahito Nakataki, Masashi Ohta, 濱谷 沙世, 松浦 可苗, 吉田 玲於奈, Naomi Kameoka, Takeo Tominaga, 坂本 新介, Hidehiro Umehara, Makoto Kinoshita, Hiroko Kubo, Shinya Watanabe, Shusuke Numata, Satsuki Sumitani and Tetsuro Ohmori :
統合失調症患者の否定的・肯定的自動思考と臨床要因との関連,
第13回統合失調症学会, Mar. 2018.
11. Hidehiro Umehara :
強迫性障害の末梢白血球におけるセロトニントランスポーター遺伝子のメチル化とmRNA解析,
第9回脳科学クラスター・ミニリトリート, Feb. 2018.
12. 青井 駿, Hidehiro Umehara, 黒田 一駿, Nobuaki Yamamoto and Tetsuro Ohmori :
幻覚妄想状態の治療後に前頭葉機能低下が残存したパーキンソン病の一例,
第58回中国・四国精神神経学会, Nov. 2017.
13. Hidehiro Umehara and Tetsuro Ohmori :
行動特性に隠れててんかん発作が見逃されていた広汎性発達障害の一例,
第58回中国・四国精神神経学会, Nov. 2017.
14. Hidehiro Umehara, Shinya Watanabe, Makoto Kinoshita, Yukiko Tomioka, Masahito Nakataki, 畠山 豊, 中原 潔, Takeshi Nikawa, Shusuke Numata and Tetsuro Ohmori :
うつ病における血漿グルタミン,グルタミン酸,グルタミン/グルタミン酸比,
第27回日本臨床精神神経薬理学会, Nov. 2017.
15. Hidehiro Umehara, Shusuke Numata, Shinya Watanabe, Satsuki Sumitani and Tetsuro Ohmori :
Altered Serotonin transporter mRNA expression in the peripheral leukocytes of obsessive-compulsive disorder,
第47回日本神経精神薬理学会・第39回日本生物学的精神医学会 合同年会, Sep. 2017.
16. Shusuke Numata, Hidehiro Umehara and Tetsuro Ohmori :
DNA methylation of the serotonin transporter gene in obsessive-compulsive disorder.,
第39回日本生物学的精神医学会, Sep. 2017.
17. Masatoshi Inoshita, Makoto Kinoshita, Hidehiro Umehara, Masahito Nakataki, Atsushi Tajima, 池田 匡志, 丸山 惣一郎, 山森 英長, 金沢 徹文, 下寺 信次, 橋本 亮太, Issei Imoto, 米田 博, 岩田 仲生, Shusuke Numata and Tetsuro Ohmori :
C-reactive protein and schizophrenia; A Mendelian Randomization approach.,
第12回日本統合失調症学会, Mar. 2017.
18. Hidehiro Umehara, Shusuke Numata, Atsushi Tajima, Issei Imoto, Satsuki Sumitani and Tetsuro Ohmori :
GWASによる強迫性障害の薬物反応性関連パスウエイの同定,
第26回日本臨床精神神経薬理学会, Nov. 2016.
19. Sayo Hamatani, Masahito Tomotake, Hidehiro Umehara, Tomoya Takeda and Tetsuro Ohmori :
児童養護施設で暮らす小6男児の癇癪弱化と職員へのペアレントトレーニング,
第42回日本認知・行動療法学会, Oct. 2016.
20. Hidehiro Umehara, 中村 公哉 and 小池 香代子 :
リスペリドン持効性懸濁注射液が有効であった神経性無食欲症男児の症例,
第46回日本神経精神薬理学会, Jul. 2016.
21. Hidehiro Umehara :
思春期の摂食障害女児の症例,
第28回日本総合病院精神医学会総会, Nov. 2015.
22. Junichi Iga, Shinya Watanabe, Shusuke Numata, Hidehiro Umehara, Akira Nishi, Makoto Kinoshita, Masatoshi Inoshita, 下寺 信次, 藤田 博一 and Tetsuro Ohmori :
うつ病患者における5HTTLPR,DNAメチル化,遺伝子発現の関連研究,
第25回日本臨床精神薬理学会, Oct. 2015.
23. Shinya Watanabe, Junichi Iga, Hidehiro Umehara, Shusuke Numata and Tetsuro Ohmori :
日本人におけるセロトニントランスポーター多型とうつ病との関連研究,
第37回日本生物学的精神医学会, Sep. 2015.
24. Hidehiro Umehara, Shusuke Numata, Satsuki Sumitani and Tetsuro Ohmori :
強迫性障害の治療反応性とセロトニントランスポータ遺伝子多型との関連,
第37回日本生物学的精神医学会, Sep. 2015.
25. Masatoshi Inoshita, Shusuke Numata, Atsushi Tajima, Makoto Kinoshita, Hidehiro Umehara, 山森 英長, 橋本 亮太, Issei Imoto and Tetsuro Ohmori :
細胞異種性を考慮した末梢血白血球のDNAメチル化の性差の検討,
第37回日本生物学的精神医学会, Sep. 2015.
26. Hidehiro Umehara, Shusuke Numata, Satsuki Sumitani and Tetsuro Ohmori :
HTR2A -1438G/A多型と強迫性障害の治療反応性との遺伝関連研究,
第7回日本不安症学会学術大会, Feb. 2015.
27. Hidehiro Umehara, Shusuke Numata, Atsushi Tajima, Issei Imoto, Satsuki Sumitani and Tetsuro Ohmori :
ゲノムワイド関連解析による強迫性障害の薬物反応性予測遺伝子多型の検討,
第7回日本不安症学会学術大会, Feb. 2015.
28. Hidehiro Umehara, Shusuke Numata, Atsushi Tajima, Makoto Kinoshita, 仲秋 秀太郎, Issei Imoto, Satsuki Sumitani and Tetsuro Ohmori :
BDNF Val66Met多型と強迫性障害;メタ解析ならびに治療反応性,
第24回日本臨床精神神経薬理学会, Nov. 2014.
29. Hidehiro Umehara, Shusuke Numata, Atsushi Tajima, Makoto Kinoshita, 仲秋 秀太郎, Issei Imoto, Satsuki Sumitani and Tetsuro Ohmori :
COMT Val158Met多型と強迫性障害の遺伝子関連ならびにメタ解析研究,
第36回日本生物学的精神医学会, Sep. 2014.
30. Hidehiro Umehara, 中村 公哉, 小池 香代子 and Tetsuro Ohmori :
リスペリドン持効性懸濁注射液の使用が有効であった神経性無食欲症の一症例,
第53回中国・四国精神神経学会, Nov. 2012.
31. Hidehiro Umehara, Satsuki Sumitani and Tetsuro Ohmori :
胸腹部の不快感を主訴としたレストレスレッグズ症候群の一症例,
第49回日本心身医学会総会, Jun. 2008.

Et cetera, Workshop:

1. 武田 知也, 福留 広大 and Hidehiro Umehara :
メタ認知的モニタリングと否定的・肯定的自動思考との関連,
第6回CEPD研究会, May 2021.
2. Tomohiko Nakayama, Hidehiro Umehara, Yukiko Tomioka, 上敷領 俊晴, 淵上 学, 岡田 剛, 増田 瑠見子, Kazuaki Mawatari, Masahito Nakataki, Shusuke Numata, Akira Takahashi, 岡本 泰昌 and Tetsuro Ohmori :
うつ病におけるキヌレニン経路の変化,
第12回脳科学クラスターミニリトリート, Feb. 2021.
3. Tomohiko Nakayama, Hidehiro Umehara, Yukiko Tomioka, 上敷領 俊晴, 淵上 学, 岡田 剛, 増田 瑠見子, Kazuaki Mawatari, Masahito Nakataki, Shusuke Numata, Akira Takahashi, 岡本 泰昌 and Tetsuro Ohmori :
うつ病におけるキヌレニン経路の変化,
第5回メタボロームシンポジウム, Dec. 2020.
4. Hidehiro Umehara, Tomoya Takeda, 松浦 可苗, 吉田 玲於奈, 冨永 隆太, 梶田 美香, 谷口 若葉 and Tetsuro Ohmori :
社会認知リハビリテーションによる児童思春期自閉スペクトラム症の社会認知機能の変化,
第19回精神疾患と認知機能研究会, Nov. 2019.
5. Hidehiro Umehara, Tomoya Takeda, 松浦 可苗, 吉田 玲於奈, 梶田 美香, 谷口 若葉 and Tetsuro Ohmori :
児童思春期自閉スペクトラム症の社会認知障害に対する社会認知ならびに対人関係のトレーニング(Social Cognition and Interaction Training: SCIT)の効果検証,
第5回CEPD研究会, May 2019.
6. 武田 知也, Masahito Nakataki, Masashi Ohta, 濱谷 沙世, 松浦 可苗, 吉田 玲於奈, Naomi Kameoka, Takeo Tominaga, 坂本 新介, Hidehiro Umehara, Makoto Kinoshita, Hiroko Kubo, Shinya Watanabe, Shusuke Numata, Satsuki Sumitani and Tetsuro Ohmori :
統合失調症患者における神経認知機能と否定的・肯定的認知の関連.,
第4回CEPD会, Mar. 2018.
7. Hidehiro Umehara :
広汎性発達障害の行動特性に隠れて見逃されていたてんかん発作,
第38回Neuroscience Seminar Tokushima, Sep. 2017.
8. Hidehiro Umehara, Shinya Watanabe, Makoto Kinoshita, Yukiko Tomioka, Masahito Nakataki, 畠山 豊, 中原 潔, Takeshi Nikawa, Shusuke Numata and Tetsuro Ohmori :
うつ病のメタボローム解析,
第2回メタボローム解析シンポジウム, Jun. 2017.
9. Hidehiro Umehara, Shusuke Numata and Tetsuro Ohmori :
うつ病の末梢血におけるメタボローム解析,
第35回躁うつ病の薬理・生化学的研究懇話会, Nov. 2016.

Grants-in-Aid for Scientific Research (KAKEN Grants Database @ NII.ac.jp)

  • 自閉スペクトラム症社会認知機能改善プログラムの有効性への内在性オキシトシンの関与 (Project/Area Number: 21K15714 )
  • Association study of the polymorphic region and methylation in the serotonin transporter gene promoter in the clinical response to drug treatment in obsessive-compulsive disorder (Project/Area Number: 15K19734 )
  • Search by Researcher Number (90645798)